Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening study.

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ (2011) 1.88

Does acupuncture have a role in the treatment of threatened miscarriage? Findings from a feasibility randomised trial and semi-structured participant interviews. BMC Pregnancy Childbirth (2016) 1.39

Association between first-trimester vaginal bleeding and miscarriage. Obstet Gynecol (2009) 1.00

Patterns and predictors of vaginal bleeding in the first trimester of pregnancy. Ann Epidemiol (2010) 1.00

Risk of preterm delivery in relation to vaginal bleeding in early pregnancy. Eur J Obstet Gynecol Reprod Biol (2007) 0.91

Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis. Reprod Biol Endocrinol (2012) 0.88

Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. Am J Pathol (2007) 0.86

Evidence of placental haemorrhage and preterm delivery. BJOG (2010) 0.81

Vaginal bleeding in early pregnancy and preterm birth: systemic review and analysis of heterogeneity. J Matern Fetal Neonatal Med (2010) 0.81

Acupuncture as a therapeutic treatment option for threatened miscarriage. BMC Complement Altern Med (2012) 0.81

Pregnancy outcome in women with threatened miscarriage: a year study. Mater Sociomed (2012) 0.78

The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. J Reprod Infertil (2014) 0.77

Perinatal outcomes in singleton and twin pregnancies following first-trimester bleeding. J Perinatol (2014) 0.76

The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update (2016) 0.76

A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol (2012) 0.75

The effects of subchorionic hematoma on pregnancy outcome in patients with threatened abortion. J Turk Ger Gynecol Assoc (2014) 0.75

Late pregnancy outcomes in women with vaginal bleeding in their first trimester. J Obstet Gynaecol India (2013) 0.75

Bleeding in Early Pregnancy. Med J Armed Forces India (2011) 0.75

Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial. Int J Fertil Steril (2016) 0.75

A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med (2011) 6.11

Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11

First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med (2005) 4.89

Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol (2004) 4.10

The National Children's Study: a 21-year prospective study of 100,000 American children. Pediatrics (2006) 3.16

Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn (2013) 2.87

Assisted reproductive technology and pregnancy outcome. Obstet Gynecol (2005) 2.77

A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol (2007) 2.73

Evaluation of third-degree and fourth-degree laceration rates as quality indicators. Obstet Gynecol (2015) 2.64

The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology (2013) 2.64

Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60

Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol (2008) 2.52

Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med (2013) 2.48

Responses by pregnant Jehovah's Witnesses on health care proxies. Obstet Gynecol (2004) 2.45

First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40

Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol (2013) 2.33

First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31

Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol (2008) 2.24

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol (2012) 2.24

Intrapartum management of category II fetal heart rate tracings: towards standardization of care. Am J Obstet Gynecol (2013) 2.10

First-trimester sonographic screening for Down syndrome. Obstet Gynecol (2003) 2.05

Choroid plexus cyst and echogenic intracardiac focus in women at low risk for chromosomal anomalies. J Ultrasound Med (2004) 1.94

Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol (2011) 1.86

Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ (2007) 1.67

First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol (2004) 1.67

First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet Gynecol (2005) 1.64

Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metab (2008) 1.57

Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol (2010) 1.56

Scientific evidence underlying the American College of Obstetricians and Gynecologists' practice bulletins. Obstet Gynecol (2011) 1.55

Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn (2009) 1.54

Reliability of the lung-to-head ratio as a predictor of outcome in fetuses with isolated left congenital diaphragmatic hernia at gestation outside 24-26 weeks. Am J Obstet Gynecol (2007) 1.51

Optimum timing for planned delivery of uncomplicated monochorionic and dichorionic twin pregnancies. Obstet Gynecol (2012) 1.47

First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol (2004) 1.47

Thyroid dysfunction in pregnancy: the basic science and clinical evidence surrounding the controversy in management. Obstet Gynecol (2009) 1.47

Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol (2007) 1.46